# NHS Framework Colorectal Cancer Drugs \(See description below\)

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Published: 25 November 2020
- Planned start: 1 December 2020
- Planned end: 30 November 2022
- Stage: open_tender
- Procurement category: goods
- Notice ID: 7bab0bf1-b9b0-4ff4-96fc-575a944257f1-395880
- OCID: ocds-b5fd17-0c5a12da-1a60-4552-8de6-e57234f93539

## Description

The NHS Commissioning Board \(operating under the name of NHS England and NHS Improvement\) looks to establish an NHS Framework agreement \(on behalf of NHS Trusts\) for the supply of drugs licensed specifically to target epidermal growth factor receptor \(EGFR\)-expressing, RAS wild-type metastatic colorectal cancer\. Ref: Tender C1485 Period of framework: 1st December 2020\* to 30th November 2022 with an option to extend \(at the Authority's discretion\) for a further period \(or periods\) up to a total of 12 months \(i\.e\. total possible framework duration of 36 months\) All documents can be found at:health\.atamis\.co\.uk

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/7bab0bf1-b9b0-4ff4-96fc-575a944257f1-395880)